FR2729390B1 - - Google Patents
Info
- Publication number
- FR2729390B1 FR2729390B1 FR9500494A FR9500494A FR2729390B1 FR 2729390 B1 FR2729390 B1 FR 2729390B1 FR 9500494 A FR9500494 A FR 9500494A FR 9500494 A FR9500494 A FR 9500494A FR 2729390 B1 FR2729390 B1 FR 2729390B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9500494A FR2729390A1 (fr) | 1995-01-18 | 1995-01-18 | Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent |
ZA96258A ZA96258B (en) | 1995-01-18 | 1996-01-12 | New farnesyl tranferase inhibitors their preparation and the pharmaceutical compositions which contain them |
CA002211786A CA2211786A1 (fr) | 1995-01-18 | 1996-01-16 | Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent |
BR9606970A BR9606970A (pt) | 1995-01-18 | 1996-01-16 | Inibidores de farnesil transferase e as composições farmaceuticas que os contêm |
JP8522080A JPH10512560A (ja) | 1995-01-18 | 1996-01-16 | 新規なファルネシルトランスフェラーゼ阻害剤、その製造及びそれを含有する製薬学的組成物 |
TR97/00660T TR199700660T1 (xx) | 1995-01-18 | 1996-01-16 | Yeni farnezil transferaz �nleyiciler. |
US08/875,005 US5750567A (en) | 1995-01-18 | 1996-01-16 | Farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing same |
EP96901397A EP0804415A1 (fr) | 1995-01-18 | 1996-01-16 | Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent |
SK959-97A SK95997A3 (en) | 1995-01-18 | 1996-01-16 | Farnesyl transferase inhibitors, preparation thereof and |
KR1019970704859A KR19980701469A (ko) | 1995-01-18 | 1996-01-16 | 신규한 파르네실 전이 효소 억제제, 이의 제조방법 및 이를 함유하는 약학 조성물(novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing same) |
PCT/FR1996/000067 WO1996022278A1 (fr) | 1995-01-18 | 1996-01-16 | Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent |
AU45436/96A AU4543696A (en) | 1995-01-18 | 1996-01-16 | Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing same |
CZ972282A CZ228297A3 (en) | 1995-01-18 | 1996-01-16 | Farnesyl-transferase inhibitors, process of their preparation and pharmaceutical composition containing thereof |
PL96321380A PL321380A1 (en) | 1995-01-18 | 1996-01-16 | Novel far nesil transferase inhibitors, their production and pharmaceutic compositions containing them |
CN96191528A CN1169145A (zh) | 1995-01-18 | 1996-01-16 | 新的法呢基转移酶抑制剂、其制法及其药物组合物 |
NO973222A NO973222L (no) | 1995-01-18 | 1997-07-10 | Nye farnesyl-transferase-inhibitorer, deres fremstilling samt farmasöytiske preparater inneholdende inhibitorene |
MXPA/A/1997/005270A MXPA97005270A (es) | 1995-01-18 | 1997-07-11 | Nuevos inhibidores de farnesiltransferasa, supreparacion y las composiciones farmaceuticas quelos contienen |
FI973039A FI973039A0 (fi) | 1995-01-18 | 1997-07-17 | Uusia farnesyylitransferaasin inhibiittoreita, niiden valmistus ja niitä sisältäviä farmaseuttisia koostumuksia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9500494A FR2729390A1 (fr) | 1995-01-18 | 1995-01-18 | Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2729390A1 FR2729390A1 (fr) | 1996-07-19 |
FR2729390B1 true FR2729390B1 (fr) | 1997-02-21 |
Family
ID=9475215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9500494A Granted FR2729390A1 (fr) | 1995-01-18 | 1995-01-18 | Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent |
Country Status (17)
Country | Link |
---|---|
US (1) | US5750567A (fr) |
EP (1) | EP0804415A1 (fr) |
JP (1) | JPH10512560A (fr) |
KR (1) | KR19980701469A (fr) |
CN (1) | CN1169145A (fr) |
AU (1) | AU4543696A (fr) |
BR (1) | BR9606970A (fr) |
CA (1) | CA2211786A1 (fr) |
CZ (1) | CZ228297A3 (fr) |
FI (1) | FI973039A0 (fr) |
FR (1) | FR2729390A1 (fr) |
NO (1) | NO973222L (fr) |
PL (1) | PL321380A1 (fr) |
SK (1) | SK95997A3 (fr) |
TR (1) | TR199700660T1 (fr) |
WO (1) | WO1996022278A1 (fr) |
ZA (1) | ZA96258B (fr) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR200003882T2 (tr) * | 1998-07-06 | 2001-06-21 | Janssen Pharmaceutica N.V. | Artropatilerin tedavisi için farnesil protein transferaz inhibitörleri. |
KR100745408B1 (ko) * | 1999-01-22 | 2007-08-02 | 에모리 유니버시티 | β-2',3'-디데하이드로-2',3'-디데옥시-5-플루오로사이티딘에 의해 선택된 HIV-1 돌연변이 |
FR2796946A1 (fr) * | 1999-07-30 | 2001-02-02 | Aventis Pharma Sa | Nouveaux derives 8-carbonyl chromanes, leur preparation et leur utilisation en therapeutique |
FR2796943A1 (fr) * | 1999-07-30 | 2001-02-02 | Aventis Pharma Sa | Derives de benzoxazinnes, leur procede de preparation et leur utilisation en therapeutique |
WO2006123182A2 (fr) | 2005-05-17 | 2006-11-23 | Merck Sharp & Dohme Limited | Sulfones de cyclohexyle pour le traitement du cancer |
GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
JP5328640B2 (ja) | 2006-04-19 | 2013-10-30 | ノバルティス アーゲー | 6−o−置換ベンゾオキサゾールおよびベンゾチアゾール化合物ならびにcsf−1rシグナル伝達を阻害する方法 |
EP2083831B1 (fr) | 2006-09-22 | 2013-12-25 | Merck Sharp & Dohme Corp. | Procédé de traitement utilisant des inhibiteurs de synthèse d'acide gras |
US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
SI2805945T1 (sl) | 2007-01-10 | 2019-09-30 | Msd Italia S.R.L. | Amid substituirani indazoli, kot inhibitorji poli(ADP-riboza)polimeraze(PARP) |
MX2009009304A (es) | 2007-03-01 | 2009-11-18 | Novartis Ag | Inhibidores de cinasa pim y metodos para su uso. |
BRPI0812159A2 (pt) | 2007-05-21 | 2017-05-02 | Novartis Ag | inibidores de csf-1r, composições e métodos de uso |
WO2009002495A1 (fr) | 2007-06-27 | 2008-12-31 | Merck & Co., Inc. | Dérivés de 4-carboxybenzylamino utilisés en tant qu'inhibiteurs de l'histone désacétylase |
US7932036B1 (en) | 2008-03-12 | 2011-04-26 | Veridex, Llc | Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase |
WO2010114780A1 (fr) | 2009-04-01 | 2010-10-07 | Merck Sharp & Dohme Corp. | Inhibiteurs de l'activité akt |
WO2010144909A1 (fr) | 2009-06-12 | 2010-12-16 | Novartis Ag | Composés hétérocycliques fondus et leurs utilisations |
WO2011046771A1 (fr) | 2009-10-14 | 2011-04-21 | Schering Corporation | Pipéridines substituées qui accroissent l'activité de p53, et utilisations de ces composés |
EP2519517B1 (fr) | 2009-12-29 | 2015-03-25 | Dana-Farber Cancer Institute, Inc. | Inhibiteurs de kinase raf de type ii |
BR112012023021A2 (pt) | 2010-03-16 | 2016-05-31 | Dana Farber Cancer Inst Inc | compostos de indazol e seus usos |
EP2584903B1 (fr) | 2010-06-24 | 2018-10-24 | Merck Sharp & Dohme Corp. | Nouveaux composés hétérocycliques utilisés comme inhibiteurs de erk |
CN103328971B (zh) | 2010-07-28 | 2016-09-28 | 维里德克斯有限责任公司 | 急性髓细胞性白血病应答法尼基转移酶抑制剂治疗的测定方法 |
WO2012018754A2 (fr) | 2010-08-02 | 2012-02-09 | Merck Sharp & Dohme Corp. | Inhibition à médiation par interférence arn de caténine (protéine associée à cadhérine), expression du gène bêta 1 (ctnnb1) à l'aide de petit acide nucléique interférent (sian) |
EP3587574B1 (fr) | 2010-08-17 | 2022-03-16 | Sirna Therapeutics, Inc. | Inhibition médiée par des arn interférents de l'expression génique du virus de l'hépatite b (vhb) à l'aide de petits acides nucléiques interférents (pani) |
US8883801B2 (en) | 2010-08-23 | 2014-11-11 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors |
WO2012030685A2 (fr) | 2010-09-01 | 2012-03-08 | Schering Corporation | Dérivés d'indazole utilisables en tant qu'inhibiteurs de la voie erk |
US9242981B2 (en) | 2010-09-16 | 2016-01-26 | Merck Sharp & Dohme Corp. | Fused pyrazole derivatives as novel ERK inhibitors |
EP2632472B1 (fr) | 2010-10-29 | 2017-12-13 | Sirna Therapeutics, Inc. | Inhibition facilitée par l'interférence d'arn de l'expression d'un gène au moyen d'acides nucléiques interférents courts (sina) |
WO2012087772A1 (fr) | 2010-12-21 | 2012-06-28 | Schering Corporation | Dérivés d'indazole utiles en tant qu'inhibiteurs de erk |
WO2012145471A1 (fr) | 2011-04-21 | 2012-10-26 | Merck Sharp & Dohme Corp. | Inhibiteurs du récepteur du facteur de croissance 1 analogue à l'insuline |
US9023865B2 (en) | 2011-10-27 | 2015-05-05 | Merck Sharp & Dohme Corp. | Compounds that are ERK inhibitors |
JP6106685B2 (ja) | 2011-11-17 | 2017-04-05 | ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド | C−jun−n−末端キナーゼ(jnk)の阻害剤 |
EP3919620A1 (fr) | 2012-05-02 | 2021-12-08 | Sirna Therapeutics, Inc. | Compositions d'acide nucléique interférent court (sina) |
US9233979B2 (en) | 2012-09-28 | 2016-01-12 | Merck Sharp & Dohme Corp. | Compounds that are ERK inhibitors |
WO2014063068A1 (fr) | 2012-10-18 | 2014-04-24 | Dana-Farber Cancer Institute, Inc. | Inhibiteurs de cycline-dépendante kinase 7 (cdk7) |
WO2014063061A1 (fr) | 2012-10-19 | 2014-04-24 | Dana-Farber Cancer Institute, Inc. | Petites molécules marquées de façon hydrophobe en tant qu'inducteurs de la dégradation de protéine |
WO2014063054A1 (fr) | 2012-10-19 | 2014-04-24 | Dana-Farber Cancer Institute, Inc. | Inhibiteurs de kinase moelle osseuse sur chromosome x (bmx) et leurs utilisations |
PL2925888T3 (pl) | 2012-11-28 | 2018-03-30 | Merck Sharp & Dohme Corp. | Kompozycje i sposoby do stosowania w leczeniu nowotworów |
CA2895504A1 (fr) | 2012-12-20 | 2014-06-26 | Merck Sharp & Dohme Corp. | Imidazopyridines substituees en tant qu'inhibiteurs de hdm2 |
WO2014120748A1 (fr) | 2013-01-30 | 2014-08-07 | Merck Sharp & Dohme Corp. | Purines 2,6,7,8-substituées utilisées en tant qu'inhibiteurs de hdm2 |
US20160194368A1 (en) | 2013-09-03 | 2016-07-07 | Moderna Therapeutics, Inc. | Circular polynucleotides |
EP3057956B1 (fr) | 2013-10-18 | 2021-05-05 | Dana-Farber Cancer Institute, Inc. | Inhibiteurs polycycliques de la kinase cycline-dépendante 7 (cdk7) |
WO2015058126A1 (fr) | 2013-10-18 | 2015-04-23 | Syros Pharmaceuticals, Inc. | Composés hétéroaromatiques utiles dans le traitement de maladies prolifératives |
US10017477B2 (en) | 2014-04-23 | 2018-07-10 | Dana-Farber Cancer Institute, Inc. | Janus kinase inhibitors and uses thereof |
US9862688B2 (en) | 2014-04-23 | 2018-01-09 | Dana-Farber Cancer Institute, Inc. | Hydrophobically tagged janus kinase inhibitors and uses thereof |
JO3589B1 (ar) | 2014-08-06 | 2020-07-05 | Novartis Ag | مثبطات كيناز البروتين c وطرق استخداماتها |
US10870651B2 (en) | 2014-12-23 | 2020-12-22 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (CDK7) |
JP6861166B2 (ja) | 2015-03-27 | 2021-04-21 | ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド | サイクリン依存性キナーゼの阻害剤 |
EP3307728A4 (fr) | 2015-06-12 | 2019-07-17 | Dana Farber Cancer Institute, Inc. | Thérapie d'association utilisant des inhibiteurs de transcription et des inhibiteurs de kinases |
PT3385395T (pt) | 2015-08-17 | 2020-05-06 | Kura Oncology Inc | Métodos de tratamento de doentes com cancro usando inibidores da farnesiltransferase |
JP7028766B2 (ja) | 2015-09-09 | 2022-03-02 | ダナ-ファーバー キャンサー インスティテュート, インコーポレイテッド | サイクリン依存性キナーゼの阻害剤 |
JOP20190055A1 (ar) | 2016-09-26 | 2019-03-24 | Merck Sharp & Dohme | أجسام مضادة ضد cd27 |
MX2019005065A (es) | 2016-11-03 | 2019-08-21 | Kura Oncology Inc | Metodos de tratamiento de pacientes con cancer con inhibidores de farnesiltransferasa. |
AU2018252546A1 (en) | 2017-04-13 | 2019-10-10 | Sairopa B.V. | Anti-SIRPα antibodies |
US10947234B2 (en) | 2017-11-08 | 2021-03-16 | Merck Sharp & Dohme Corp. | PRMT5 inhibitors |
WO2019113269A1 (fr) | 2017-12-08 | 2019-06-13 | Kura Oncology, Inc. | Méthodes de traitement de patients cancéreux avec des inhibiteurs de la farnésyltransférase |
WO2019148412A1 (fr) | 2018-02-01 | 2019-08-08 | Merck Sharp & Dohme Corp. | Anticorps bispécifiques anti-pd-1/lag3 |
US11981701B2 (en) | 2018-08-07 | 2024-05-14 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
US11993602B2 (en) | 2018-08-07 | 2024-05-28 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
WO2020190604A1 (fr) | 2019-03-15 | 2020-09-24 | Kura Oncology, Inc. | Méthodes de traitement de patients cancéreux avec des inhibiteurs de la farnésyltransférase |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5504212A (en) * | 1992-10-29 | 1996-04-02 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5536750A (en) * | 1992-10-29 | 1996-07-16 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5686472A (en) * | 1992-10-29 | 1997-11-11 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5523456A (en) * | 1994-09-29 | 1996-06-04 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
-
1995
- 1995-01-18 FR FR9500494A patent/FR2729390A1/fr active Granted
-
1996
- 1996-01-12 ZA ZA96258A patent/ZA96258B/xx unknown
- 1996-01-16 KR KR1019970704859A patent/KR19980701469A/ko not_active Application Discontinuation
- 1996-01-16 AU AU45436/96A patent/AU4543696A/en not_active Abandoned
- 1996-01-16 BR BR9606970A patent/BR9606970A/pt not_active Application Discontinuation
- 1996-01-16 TR TR97/00660T patent/TR199700660T1/xx unknown
- 1996-01-16 JP JP8522080A patent/JPH10512560A/ja active Pending
- 1996-01-16 CA CA002211786A patent/CA2211786A1/fr not_active Abandoned
- 1996-01-16 WO PCT/FR1996/000067 patent/WO1996022278A1/fr not_active Application Discontinuation
- 1996-01-16 CN CN96191528A patent/CN1169145A/zh active Pending
- 1996-01-16 SK SK959-97A patent/SK95997A3/sk unknown
- 1996-01-16 CZ CZ972282A patent/CZ228297A3/cs unknown
- 1996-01-16 EP EP96901397A patent/EP0804415A1/fr not_active Ceased
- 1996-01-16 PL PL96321380A patent/PL321380A1/xx unknown
- 1996-01-16 US US08/875,005 patent/US5750567A/en not_active Expired - Fee Related
-
1997
- 1997-07-10 NO NO973222A patent/NO973222L/no unknown
- 1997-07-17 FI FI973039A patent/FI973039A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
CA2211786A1 (fr) | 1996-07-25 |
KR19980701469A (ko) | 1998-05-15 |
FI973039A (fi) | 1997-07-17 |
PL321380A1 (en) | 1997-12-08 |
ZA96258B (en) | 1996-08-01 |
SK95997A3 (en) | 1997-12-10 |
TR199700660T1 (xx) | 1998-01-21 |
CN1169145A (zh) | 1997-12-31 |
BR9606970A (pt) | 1997-11-04 |
EP0804415A1 (fr) | 1997-11-05 |
NO973222D0 (no) | 1997-07-10 |
CZ228297A3 (en) | 1997-10-15 |
NO973222L (no) | 1997-07-10 |
US5750567A (en) | 1998-05-12 |
MX9705270A (es) | 1997-10-31 |
JPH10512560A (ja) | 1998-12-02 |
FI973039A0 (fi) | 1997-07-17 |
FR2729390A1 (fr) | 1996-07-19 |
WO1996022278A1 (fr) | 1996-07-25 |
AU4543696A (en) | 1996-08-07 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |